Platform facilitates improved stroke care through AI

Digital heath company Brainomix has developed AI algorithms to help doctors make quick, accurate decisions for patients suffering from a stroke, helping more receive better care and outcomes. This year it has been estimated that around 100,000 people in the UK will have a stroke and every second counts for crucial decisions about diagnosis and treatments to be made.

A spin-out in 2010 from the University of Oxford’s preclinical stroke lab, part of the Nuffield Department of Clinical Neurosciences, Brainomix’s e-Stroke platform analyses images from simple CT scans, providing detailed real-time information – available to view remotely – on the extent and nature of damage to the brain.

Co-founder and CEO Dr Michalis Papadakis said: "In 2023 we were delighted to receive FDA approval to take our e-ASPECTS tool to the US, where more than 800,000 people suffer a stroke each year. This tool, part of the Brainomix 360 package of AI technologies, supports physicians who are making time-sensitive, critical decisions around transfer and treatment, strengthening networks and facilitating an improved stroke service.”

Studies have shown that implementing e-Stroke reduces arrival-to-discharge times by more than one hour, as well as tripling the number of stroke patients going on to achieve functional independence, the company reported.

It has been adopted by more than 30 healthcare systems worldwide and has raised over £30m in public and private funding. A patient is scanned using e-Stroke every five minutes, with results available in just 60 seconds.

Brainomix has now developed similar AI-powered imaging platforms for lung disease and cancer. The company is regularly showcased by government as a leader in the health data revolution and as an example of the potential for academic spinouts to translate innovative research into real-world impact that can benefit patients and healthcare providers.

More information online